TACE Plus Drug Combination Effective in Liver Cancer
March 7, 2025, by Carmen Phillips Some people with liver cancer are treated with a procedure called transarterial chemoembolization, or...
drug
New drug approach shows promise in treating metabolic liver diseases
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental...
Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can’t be treated with surgery | Health and Wellness News
Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the...
ZyVersa to Showcase Breakthrough Kidney Disease Drug at JPM Healthcare Conference 2025
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
